---
figid: PMC7433817__CAM4-9-6020-g006
figtitle: Schematic chart of drug sensitivity‐related genes in the current study with
  proposed interaction or regulatory pathway in ccRCC
organisms:
- NA
pmcid: PMC7433817
filename: CAM4-9-6020-g006.jpg
figlink: pmc/articles/PMC7433817/figure/cam43281-fig-0006/
number: F6
caption: Schematic chart of drug sensitivity‐related genes in the current study with
  proposed interaction or regulatory pathway in ccRCC. Solid lines represent reported
  interaction. Dashed lines represent proposed interaction. Arrows indicate stimulatory
  and T‐shapes indicate inhibitory
papertitle: 'Comprehensive analysis of copy number variance and sensitivity to common
  targeted therapy in clear cell renal cell carcinoma: In silico analysis with in
  vitro validation.'
reftext: Yuqing Li, et al. Cancer Med. 2020 Aug;9(16):6020-6029.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8647167
figid_alias: PMC7433817__F6
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC7433817__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7433817__CAM4-9-6020-g006.html
  '@type': Dataset
  description: Schematic chart of drug sensitivity‐related genes in the current study
    with proposed interaction or regulatory pathway in ccRCC. Solid lines represent
    reported interaction. Dashed lines represent proposed interaction. Arrows indicate
    stimulatory and T‐shapes indicate inhibitory
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FGFR1
  - FGFR2
  - FGFR3
  - FGFR4
  - FGFRL1
  - PDGFRB
  - PDGFRA
  - CDKN2A
  - MTOR
  - KIT
  - AXL
  - ADCYAP1
  - RET
  - MKNK2
  - MKNK1
  - CTBP1
  - GNAS
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - LRP10
  - LRP4
  - CCNE1
  - ACRBP
  - MDM2
  - XRCC1
  - PBRM1
  - Pazopanib
  - Temsirolimus
  - Axitinib
  - Sunitinib
  - Cabozantinib
  - ARF
  - RCC tumor
---
